Olympus Marks 100th Anniversary on October 11th with Yearlong Calendar of Social Responsibility Initiatives

CENTER VALLEY, Pa., Sept. 26, 2019 /PRNewswire/ — Olympus, a global technology leader, crafting innovative optical and digital solutions in medical technologies; life sciences; industrial solutions; and cameras and audio products, announced the launch of corporate social responsibility initiatives in recognition and celebration of the company’s 100th anniversary this year. Guided by our corporate philosophy of making people’s lives healthier, safer and more fulfilling, the 100th anniversary initiatives are focused on raising cancer awareness and inspiring youth education.

Olympus has been a pioneer in the advent of colonoscopy, which is considered the “gold standard” for colorectal cancer screening, diagnosis, and treatment. Through support of leading colorectal cancer advocacy organizations, Olympus is funding a series of awareness-building national events organized by the Colon Cancer Alliance and the Colon Cancer Coalition and providing free colonoscopies to 100 at-risk community members. Additionally, Olympus is gathering and presenting 100 colorectal cancer survivor video stories to help put a face to the more than one million survivors of the disease.

Locally, within the Lehigh Valley of Pennsylvania where Olympus Corporation of the Americas is headquartered, the Bradbury Sullivan LGBT Community Center is using financial support from Olympus to fund a colorectal cancer screening campaign that will promote awareness and bridge healthcare disparity gaps amongst the LGBT community members. Other local Olympus support for cancer screening and awareness includes sponsorship of the Pediatric Cancer Foundation of the Lehigh Valley’s 30 Days, 30 Stories, taking place during Pediatric Cancer Awareness Month. This campaign celebrates the lives of children who are fighting or have fought cancer diagnoses and spreads awareness about resources for families affected by childhood cancer.

Because eradicating diseases such as colon cancer will depend on the preparation of younger generations to address scientific challenges, Olympus is supporting youth education campaigns that further knowledge and opportunities, with a special focus on those who are underserved. Through the BioBus program, Olympus is giving underserved students in New York City the chance to discover, explore and pursue science. Two mobile science laboratories, equipped with Olympus microscopes, various specimens and artifacts, and staffed by scientists, visit pre-K through 12th-grade classes for inquiry-based, hands-on, standards-aligned lab sessions. These targeted interventions nurture interest and foster science identity in underserved populations where science achievement gaps are large. BioBus has reached a quarter-million students in the past decade and plans to reach another 750,000 in the next ten years.

Additionally in support of youth education, Olympus is supporting a range of Lehigh Valley, PA, nonprofit youth organizations and initiatives including the Fé Foundation for students advancing to college or vocational school and the STEM (Science, Technology, Engineering, and Math) Programming of the Girl Scouts of Eastern PA (GSEP).

“Olympus is looking ahead to the next 100 years of innovation, and through our partnerships with nonprofit organizations, we are helping communities fight a disease that prematurely takes lives, and we are helping to cultivate young minds for the work that lies ahead,” said Nacho Abia, President and CEO of Olympus Corporation of the Americas. “I am proud to help lead a company that for so long has helped illuminate the details of our world for scientists, doctors, engineers, artists, and many others, and in doing so, has brought healing, relief, hope, and joy to the world.”

If you are a colon cancer survivor, please consider sharing your story with us by December 31, 2019. See the submission guidelines here.

About Olympus
Olympus is a global technology leader, crafting innovative optical and digital solutions in medical technologies; life sciences; industrial solutions; and cameras and audio products. Our solutions enable specialists to look inside the human body, further scientific research, ensure public safety and capture images of the world.

Throughout our 100-year history, Olympus has focused on being true to society and making people’s lives healthier, safer and more fulfilling. Olympus Corporation of the Americas (OCA)—a wholly owned subsidiary of Olympus Corporation in Tokyo, Japan—is headquartered in Center Valley, Pennsylvania and employs more than 5,300 employees throughout locations in North and South America. For more information, visit olympusamerica.com and truetolife.com.

Olympus…True to You. True to Society. True to LIFE.

View original content to download multimedia:http://www.prnewswire.com/news-releases/olympus-marks-100th-anniversary-on-october-11th-with-yearlong-calendar-of-social-responsibility-initiatives-300926051.html

SOURCE Olympus

Staff

Recent Posts

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…

3 hours ago

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

17 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

18 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

18 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

19 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

21 hours ago